Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Conditions
Interventions
AbobotulinumtoxinA dose 1
Placebo
+2 more
Locations
8
United States
Galderma Research Site
Encinitas, California, United States
Galderma Research Site
Encino, California, United States
Galderma Research Site
Boynton Beach, Florida, United States
Galderma Research Site
Miami, Florida, United States
Galderma Research Site
New Orleans, Louisiana, United States
Galderma Research Site
New Orleans, Louisiana, United States
Start Date
September 25, 2019
Primary Completion Date
December 30, 2019
Completion Date
June 4, 2020
Last Updated
August 26, 2022
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions